Spanish Translations

Neurology® 2017; Vol. 89

Epilepsy in multiple sclerosis: A nationwide population-based register study. Burman et al. 89(24):2462-2468.

Blood pressure from mid‐ to late life and risk of incident dementia. McGrath et al. 89(24):2447-2454.

Serum neurofilament light in familial Alzheimer disease: A marker of early neurodegeneration. Weston et al. 89(21):2167-2175.

Relevance of supraventricular runs detected after cerebral ischemia. Weber-Krüger et al. 89(15);1545-1552.

Some light in the shadows of atrial fibrillation and stroke: To look or not to look. Ustrell et al. 89(15):1536-1537.

Antibody-associated CNS syndromes without signs of inflammation in the elderly. Escudero et al. 89(14):1471-1475.

Medication overuse headache: An entrenched idea in need of scrutiny. Scher et al. 89(12):1296-1304.
 

Neurology® 2010; Vol. 75

MS quality of life, depression, and fatigue improve after mindfulness training: A randomized trial, Grossman et al. 75(13):1141-1149

Regional patterns of brain tissue loss associated with depression in Parkinson disease, Kostić et al. 75(10):857-863

Depressive symptoms and risk of dementia: The Framingham Heart Study, Saczynski et al. 75(1):35-41

 

Neurology® 2010; Vol. 74

Shared genetic factors in migraine and depression: Evidence from a genetic isolate, Stam et al. 74(4):288-294

 

Neurology® 2009; Vol. 73

Practice Parameter update: Management issues for women with epilepsy—Focus on pregnancy (an evidence-based review): Obstetrical complications and change in seizure frequency: Report of the Quality Standards Subcommittee and Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and American Epilepsy Society, Harden et al. 73(2):126-132

Practice Parameter update: Management issues for women with epilepsy—Focus on pregnancy (an evidence-based review): Teratogenesis and perinatal outcomes: Report of the Quality Standards Subcommittee and Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and American Epilepsy Society, Harden et al. 73(2):133-141

 

Neurology® 2008; Vol. 70

History of depression, depressive symptoms, and medial temporal lobe atrophy and the risk of Alzheimer disease, Geerlilngs et al. 70(15):1258-1264

Psychological distress, major depressive disorder, and risk of stroke, Surtees et al. 70(10):788-794

 

Neurology® 2007; Vol. 69

Reassessment: Neuroimaging in the emergency patient presenting with seizure (an evidence-based review): Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology, Harden et al. 69(18):1772-1780

History of childhood maltreatment is associated with comorbid depression in women with migraine, Tietjen et al. 69(10):959-968

 

Neurology® 2007; Vol. 68 No. 15

When the patient knows best: A challenge in translating clinical trial evidence into practice, Vickrey 68(15):1172-1173

American Academy of Neurology position statement on physician reporting of medical conditions that may affect driving competence, Bacon et al. 68(15):1174-1177

Intramedullary spinal cord abscess in a healthy woman, Applebee et al. 68(15):1230

 

Neurology® 2007; Vol. 68 No. 14

The association of mood with quality of life ratings in epilepsy, Tracy et al. 68(14):1101-1107

Ropinirole 24-hour prolonged release: Randomized, controlled study in advanced Parkinson disease, Pahwa et al. 68(14):1108-1115

Evaluation of LRRK2 G2019S penetrance: Relevance for genetic counseling in Parkinson disease, Goldwurm et al. 68(14):1141-1143

Intravenous immunoglobulin therapy for Miller Fisher syndrome, Mori et al. 68(14):1144-1146

Tetracycline delays ocular motility decline in chronic progressive external ophthalmoplegia, Omar and Johnson 68(14):1159-1160

 

Neurology® 2007; Vol. 68 No. 13

AMPA potentiator treatment of cognitive deficits in Alzheimer disease, Chappell et al. 68(13):1008-1012

Fever after subarachnoid hemorrhage: Risk factors and impact on outcome, Fernandez et al. 68(13):1013-1019

The value of detecting anti-VZV IgG antibody in CSF to diagnose VZV vasculopathy, Nagel et al. 68(13):1069-1073

NMO-IgG in the diagnosis of neuromyelitis optica, Jarius et al. 68(13):1076-1077

Clinical manifestations and treatment of rheumatoid pachymeningitis, Starosta and Brandwein 68(13):1079-1080

Efficacy of propafenone in paramyotonia congenita, Alfonsi et al. 68(13):1080-1081

 

Neurology® 2007; Vol. 68 No. 12

Can antibodies in serum predict the presence of microscopic tumors?, Voltz 68(12):887-888

Orchiectomy for suspected microscopic tumor in patients with anti-Ma2-associated encephalitis, Mathew et al. 68(12):900-905

Decreased frontal choline and neuropsychological performance in preclinical Huntington disease, Gómez-Ansón et al. 68(12):906-910

Progression of isolated middle cerebral artery stenosis into moyamoya disease, Choi et al. 68(12):954

 

Neurology® 2007; Vol. 68 No. 11

Clinicopathologic features of frontotemporal dementia with Progranulin sequence variation, Spina et al. 68(11):820-827

IV immunoglobulin in patients with myasthenia gravis: A randomized controlled trial, Zinman et al. 68(11):837-841

Long-term outcome of elective stenting for symptomatic intracranial vertebrobasilar stenosis, Jiang et al. 68(11):856-858

 

Neurology® 2007; Vol. 68 No. 10

Assessment: Use of epidural steroid injections to treat radicular lumbosacral pain: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology, Armon et al. 68(10):723-729

High-resolution MRI of isolated intraluminal clot of the common carotid artery, Boussel et al. 68(10):788

 

Neurology® 2007; Vol. 68 No. 9

CIDP-induced spinal canal obliteration presenting as lumbar spinal stenosis, Diederichs et al. 68(9):701

 

Neurology® 2007; Vol. 68 No. 8

Outcomes and predictors of chronic daily headache in adolescents: A 2-year longitudinal study, Wang et al. 68(8):591-596

 

Neurology® 2007; Vol. 68 No. 7

Factors associated with depression in patients referred to headache specialists, Jelinski et al. 68(7):489-495

 

Neurology® 2007; Vol. 68 No. 6

Determining future stroke risk using MRI: New data, new questions, Tong and Caplan 68(6):398-399

Comparison of levetiracetam and controlled-release carbamazepine in newly diagnosed epilepsy, Brodie et al. 68(6):402-408

Acute ischemic lesions of varying ages predict risk of ischemic events in stroke/TIA patients, Sylaja et al. 68(6):415-419

Pathologic startle following brainstem lesion, Della Marca et al. 68(6):437

Long-term outcome of bilateral pallidal deep brain stimulation for primary cervical dystonia, Hung et al. 68(6):457-459

 

Neurology® 2007; Vol. 68 No. 5

Patterns of neuropsychological impairment in frontotemporal dementia, Libon et al. 68(5):369-375

Familial effects on the clinical course of multiple sclerosis, Hensiek et al. 68(5):376-383

 

Neurology® 2007; Vol. 68 No. 4

Tuberculous cranial pachymeningitis, Thurtell et al. 68(4):298-300

Pathologic gambling in patients with restless legs syndrome treated with dopaminergic agonists, Tippmann-Peikert et al. 68(4):301-303

Late recovery from the minimally conscious state: Ethical and policy implications, Fins et al. 68(4):304-307

 

Neurology® 2007; Vol. 68 No. 3

The role of muscle biopsy in investigating isolated muscle pain, Filosto et al. 68(3):181-186

Has evidence changed practice?: Appropriateness of carotid endarterectomy after the clinical trials, Halm et al. 68(3):187-194

Outcome of noninvasive ventilation in children with neuromuscular disease, Young et al. 68(3):198-201

Sodium channels and pain, Benarroch 68(3):233-236

 

Neurology® 2007; Vol. 68 No. 2

Enzyme replacement for infantile Pompe disease: The first step toward a cure, Wagner 68(2):88-89

Neurologic phenotypes associated with acanthocytosis, Walker et al. 68(2):92-98

High prevalence of somatic symptoms and depression in women with disabling chronic headache, Tietjen et al. 68(2):134-140

Phenylpropanolamine contained in cold remedies and risk of hemorrhagic stroke, Yoon et al. 68(2):146-149

CSF pressure assessed by lumbar puncture agrees with intracranial pressure, Lenfeldt et al. 68(2):155-158

 

Neurology® 2007; Vol. 68 No. 1

NEUROLOGY: The next team, Noseworthy 68(1):6-8

Diffusion tensor imaging: Scientific advance, clinical tool, or just a pretty picture?, Little and Holloway 68(1):9-10

Diffusion tensor imaging of cingulum fibers in mild cognitive impairment and Alzheimer disease, Zhang et al. 68(1):13-19

A randomized clinical trial of coenzyme Q10 and GPI-1485 in early Parkinson disease, The NINDS NET-PD Investigators 68(1):20-28

Risk of ischemic stroke and lifetime estrogen exposure , Alonso de Leciñana et al. 68(1):33-38

Endurance training: An effective and safe treatment for patients with LGMD2I, Sveen et al. 68(1):59-61

 

Neurology® 2006; Vol. 67

Social-economic costs and quality of life of Alzheimer disease in the Canary Islands, Spain, Lopez–Bastida et al. 67(12):2186-2191

Herbicide exposure modifies GSTP1 haplotype association to Parkinson onset age: The GenePD Study, Wilk et al. 67(12):2206-2210

Efficacy of oxcarbazepine for prophylaxis against cumulative oxaliplatin-induced neuropathy, Argyriou et al. 67(12):2253-2255

Optimizing therapy of seizures in stroke patients, Ryvlin et al. 67(12 suppl 4):S3-S9

A clinical and radiographic variant of Wernicke-Korsakoff syndrome in a nonalcoholic patient, Flint et al. 67(11):2015

High seroprevalence of Epstein–Barr virus in children with multiple sclerosis, Pohl et al. 67(11):2063-2065

Locked-in syndrome resulting from bilateral cerebral peduncle infarctions, Zakaria and Flaherty 67(10):1889

Practice Parameter: Diagnostic assessment of the child with status epilepticus (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society, Riviello et al. 67(9):1542-1550

Treating MNGIE: Is reducing blood nucleosides the first cure for a mitochondrial disorder?, Chinnery and Vissing 67(8):1330-1332

Treatment of neurocysticercosis: Current status and future research needs, Nash et al. 67(7):1120-1127

Micro- and macroalbuminuria predict hemorrhagic transformation in acute ischemic stroke, Rodríguez-Yáñez et al. 67(7):1172-1177

New pharmacologic horizons in the treatment of Parkinson disease, Bonuccelli and Del Dotto 67(7 suppl 2):S30-S38

Migrainous vertigo: Prevalence and impact on quality of life, Neuhauser et al. 67(6):1028-1033

Conversion to dementia from mild cognitive disorder: The Cache County Study, Tschanz et al. 67(2):229-234

Behavioral effects of memantine in Alzheimer disease patients receiving donepezil treatment, Cummings et al. 67(1):57-63

Medication-overuse headache in patients with cluster headache, Paemeleire et al. 67(1):109-113

Hypothalamic stimulation for intractable cluster headache: Long-term experience, Leone et al. 67(1):150-152

 

Neurology® 2006; Vol. 66

The adolescent female with epilepsy: Mood, menstruation, and birth control, Harden 66(66 suppl 3):S3-S4

Elderly-onset essential tremor is associated with dementia, Benito-León et al. 66(10):1500-1505

A meta-analysis of individual patient responses to lamotrigine or carbamazepine monotherapy, Gamble et al. 66(9):1310-1317

Practice Parameter: Treatment of Parkinson disease with motor fluctuations and dyskinesia (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology, Pahwa et al. 66(7):983-995

Topiramate in essential tremor: A double-blind, placebo-controlled trial, Ondo et al. 66(5):672-677

 

Neurology® 2005; Vol. 65

Use of serum prolactin in diagnosing epileptic seizures: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology, Chen et al. 65(5):668-675

 

Neurology® 2005; Vol. 64

A prospective study of predictors of poststroke depression, Carota et al. 64(3):428-433

 

Neurology® 2004; Vol. 63

Depression and comorbidity in community-based patients with epilepsy or asthma, Ettinger et al. 63(6):1008-1014

 

Neurology® 2004; Vol. 62

 

Neurology® 2003; Vol. 61

Parámetro de Práctica: Inmunoterapia para el síndrome de Guillain-Barré: Informe del Subcomité de Normas de Calidad de la Academia Americana de Neurología (Practice parameter: Immunotherapy for Guillain–Barré syndrome: Report of the Quality Standards Subcommittee of the American Academy of Neurology), Hughes et al. 61(6):736-740

 

Neurology® 2003; Vol. 60

Practice parameter: Temporal lobe and localized neocortical resections for epilepsy: Report of the Quality Standards Subcommittee of the American Academy of Neurology, in Association with the American Epilepsy Society and the American Association of Neurological Surgeons, Engel; et al. 60(4):538-547

 

Neurology® 2000; Vol. 55

Practice parameter: Evaluating a first nonfebrile seizure in children: Report of the Quality Standards Subcommittee of the American Academy of Neurology, the Child Neurology Society, and the American Epilepsy Society, Hirtz et al. 55(5):616-623

 

Neurology® 1997; Vol. 49